Medical implications of understanding complex disease traits

Current Opinion in Biotechnology

Volumn 9, Issue 6, 1998, Pages 573-577

  Bell, John ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; AUTOIMMUNE DISEASE; DIABETES MELLITUS; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC DISORDER; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SCREENING; OBESITY; PHARMACODYNAMICS; PHARMACOGENETICS; PHARMACOKINETICS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0032403971     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(98)80134-1     Document Type: Article

References (52)

1. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). of outstanding interest Nature. 384:1996;455-458 This paper defines a new set of molecules involved in Type II diabetes characterised in families with maturity-onset diabetes of the young (MODY). The hepatocyte nuclear factor 1α gene product is involved in regulation of the transcription of a large number of genes, but its role in creating a diabetes phenotype is unclear.
2. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature. 384:1996;458-460.
3. Hani EH, Suaud L, Boutin P, Chevre JC, Durand E, Philippi A, Demenais F, Vionnet N, Furuta H, Velho G, et al. A missense mutation in hepatocyte nuclear factor-4α, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus. J Clin Invest. 101:1998;521-526.
4. Pontoglio M, Sreenan S, Roe M, Pugh W, Ostrega D, Doyen A, Pick AJ, Baldwin A, Velho G, Froguel P, et al. Defective insulin secretion in hepatocyte nuclear factor 1α-deficient mice. J Clin Invest. 101:1998;2215-2222.
5. Dunger DB, Ong KKL, Huxtable SJ, Sherriff A, Woods KA, Ahmed ML, Golding J, Pembrey ME, Ring S. Association of the INS VNTR with size at birth. of outstanding interest Nat Genet. 19:1998;98-100 Birth size has previously been associated with an increased risk of Type II diabetes. Dunger have looked at sequences thought to be responsible for the regulation of the insulin gene on chromosome 11 and shown that these correlate with birth size and so may potentially contribute to susceptibility to diabetes.
6. Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. of outstanding interest Nat Genet. 19:1998;168-270 Glucokinase mutations can produce Type II diabetes in MODY families. This paper established that glucokinase mutations in the fetus can result in reduced birth weight. This suggests that genetic factors controlling insulin secretion may be important determinants of fetal size.
7. Aitman TJ, Gotoda T, Evans AL, Imrie H, Heath KE, Trembling PM, Truman H, Wallace CA, Rahman A, Dore C, et al. Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats. Nat Genet. 16:1997;197-201.
8. Gaugier D, Froguel P, Parent V, Bernard C, Bihoreau MT, Portha B, James MR, Penicaud L, Lathrop M, Ktorza A. Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat. Nat Genet. 12:1996;38-43.
9. Lembertas AV, Perusse L, Chagnon YC, Fisler JS, Warden CH, Purcell-Huynh DA, Dionne FT, Gagnon J, Nadeau A, Lusis AJ, Bouchard C. Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest. 100:1997;1240-1247.
10. Phillips MS, Liu Q, Hammone HA, Dugan V, Hey PJ, Caskey CT, Hess JF. Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet. 13:1996;18-19.
11. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell. 83:1995;1263-1271.
12. Chua SC, Chung WK, Wu-Peng S, Zhang Y, Liu S-M, Tartaglia L, Leibel RL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science. 271:1996;994-996.
13. Wu-Peng XS, Chua SC, Okada N, Liu S-M, Nicolson M, Leibel RL. Phenotype of the obese Koletsky (f) rat due to Tyr763stop mutation in the extracellular domain of the leptin receptor (Lpr). Evidence for devicient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes. 46:1997;513-518.
14. Montague CT, Farooqi S, Whitehead JP, Soos M, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. of special interest Nature. 387:1997;903-908 Leptin deficiency in humans is rare but is responsible for early onset obesity described in this paper. This provides evidence that leptin is a regulator of energy balance in humans.
15. Kleyn PW, Fan W, Kovats SG, Lee JJ, Pulido JC, Wu Y, Berkemeier LR, Misumi DJ, Holmgren L, Charlat O, et al. Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell. 85:1996;281-290.
16. Noben-Trauth K, Naggert JK, North MA, Nishina PM. A candidate gene for the mouse mutation tubby. Nature. 380:1996;534-538.
17. Naggert JK, Fricker LD, Varlamov O, Nishina PM, Rouille Y, Steiner DF, Carroll RJ, Paigen BJ, Leiter EH. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet. 10:1995;135-142.
18. Jackson RS, Creemers JWM, Ohagi S, Raffin-Sanson M-L, Sanders L, Montague CT, Hutton JC, O'Rahilly S. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. of special interest Nat Genet. 16:1997;303-306 This paper describes a novel mechanism for human obesity resulting from a mutation in a prohormone convertase gene. This defect results in the failure to convert prohormones to their active products and may represent a general mechanism for ability.
19. Daniels SE, Bhattacharrya S, James A, Leaves NI, Young A, Hill MR, Faux JA, Ryan GF, le Souef PN, Lathrop GM, et al. A genome-wide search for quantitative trait loci underlying asthma. Nature. 383:1996;247-250.
20. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nat Genet. 15:1997;389-392.
21. Hershey GKK, Friedrich MF, Esswein L, Thomas ML, Chatila TA. The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor. New Engl J Med. 337:1997;1720-1725.
22. Mitsuyasu H, Izuhara K, Mao X-Q, Gao P-S, Arinobu Y, Enomoto T, Kawai M, Sasaki S, Dake Y, Hamasaki N, Shirakawa T, Hopkin J. Ile50Val variant of IL4Rα upregulates IgE synthesis and associates with atopic asthma. Nat Genet. 19:1998;119-120.
23. 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet. 345:1995;1213-1214.
24. 2 adrenoceptor with reported childhood asthma: population based study. BMJ. 316:1998;664.
25. 2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families. J Allergy Clin Immunol. 100:1997;261-265.
26. Moffatt MF, Cookson WOCM. Tumour necrosis factor haplotypes and asthma. Hum Mol Genet. 6:1997;551-554.
27. Moffatt MF, Schou C, Faux JA, Cookson WOCM. Germline TCR-A restriction of immunoglobulin E responses to allergen. Immunogenet. 46:1997;226-230.
28. Lernmark A, Ott J. Sometimes it's hot, sometimes it's not. Nat Genet. 19:1998;213-214.
29. Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, Terwilliger JD, Lathrop GM, Bell JI, Jewell DP. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet. 14:1996;199-202.
30. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature. 379:1996;821-823.
31. Duerr RH, Barmada MM, Zhang L, Davis S, Preston RA, Chensny LJ, Brown JL, Ehrlich GD, Weeks D, Aston CE. Linkage and association between inflammatory bowel disease and a locus on chromosome 12. of special interest Am J Hum Genet. 63:1998;95-100 Following the description of multiple linkages in inflammatory bowel disease, this paper confirms the presence of linkage on human chromosome 12 with inflammatory bowel disease and establishes evidence of an association with markers in this region.
32. Cho JH, Nicolae DL, Gold LH, Fields CT, LaBuda MC, Rohal PM, Pickles MR, Qin L, Fu Y, Mann JS, et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci USA. 95:1998;7502-7507.
33. Concannon P, Gogolin-Ewens KJ, Hinds DA, Wapelhorst B, Morrison VA, Stirling B, Mitra M, Farmer J, Williams SR, Cox NJ, et al. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. of special interest Nat Genet. 19:1998;292-296 This genome-wide screen of families with Type I diabetes reveals some of the difficulties with previous interpretations of data. It does, however, confirm the presence of several established linkages and identifies one new major potential linkage.
34. Mein CA, Esposito L, Dunn MG, Johnson GCL, Timms AE, Goy JV, Smith AN, Sebag-Montefiore L, Merriman ME, Wilson AJ, et al. A search for type I diabetes susceptibility genes in families from the United Kingdom. Nat Genet. 19:1998;297-300.
35. Easton D. Breast cancer genes - what are the real risks? Nat Genet. 16:1997;210-211.
36. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin A, McAdams M, Timmerman MM, Brody LC, Tucker MA. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. of special interest New Engl J Med. 336:1997;1401-1408 The precise contribution of BRCA1 mutations to the risk of breast cancer has been biased by its evaluation in high risk families. This study attempts to evaluate the contribution of BRCA1 mutations in a population of Ashkenazi Jews. In this group, several founder mutations are associated with a much lower risk of breast cancer than previously demonstrated.
37. Krainer M, Silva-Arrieta S, FitzGerald MG, Shimada A, Ishioka C, Kanamaru R, MacDonald DJ, Unsal H, Finkelstein DM, Bowcock A, et al. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. New Engl J Med. 20:1997;1416-1421.
38. Couch FJ, DeShano ML, Blackwood A, Calzone K, Stopper J, Campeau L, Ganguly A, Rebbeck T, Weber BL. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. New Engl J Med. 20:1997;1409-1415.
39. Athma P, Rappaport R, Swift M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet. 92:1996;130-134.
40. FitzGerald MG, Bean JM, Hedge SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ, Haber DA. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet. 15:1997;307-310.
41. Giardiello FM, Brensinger JD, Petersen GM, Luce MC, Hylind LM, Bacon JA, Booker SV, Parker RD, Hamilton SR. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. New Engl J Med. 336:1997;823-827.
42. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, Chadwick RB, Kaarianen H, Eskelinen M, Jarvinen H, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. New Engl J Med. 21:1998;1481-1487.
43. 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet. 350:1997;995-999.
44. Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AVG, Lie KI, Kastelein JP. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. of special interest New Engl J Med. 338:1998;86-93 Polymorphisms of the CETP gene define patient populations that have different rates of progression of their coronary artery disease. In one subgroup, the effect of HMG-CoA reductase inhibition is not evident. This may indicate a difference in the therapeutic effect of these drugs based on genetics.
45. Weber WW. Motulsky AG, Bobrow M, Harper PS, Scriver C. Pharmacogenetics. 1997;Oxford University Press, Oxford.
46. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517.
47. Collins FS, Guyer MS, Charkravarti A. Variations on a theme: cataloging human DNA sequence variation. Science. 278:1997;1580-1581.
48. Kruglyak L. The use of a genetic map of biallelic markers in linkage studies. Nat Genet. 17:1997;21-24.
49. Zhao LP, Aragaki C, Hse L, Quiaoit F. Mapping of complex traits by single-nucleotide polymorphisms. Am J Hum Genet. 63:1998;225-240.
50. Nickerson DA, Taylor SL, Weiss KM, Clark AG, Hutchinson RG, Stengard J, Salomaa V, Vartianinen E, Boerwinkle E, Sing CF. DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. of outstanding interest Nat Genet. 19:1998;233-240 This important paper defines the extent of polymorphism in the lipoprotein lipase gene. The extensive polymorphism seen within this gene indicates how difficult it may be to define functional variants.
51. Clark AG, Weiss KM, Nickerson DA, Taylor SL, Buchanan A, Stengard J, Salomaa V, Vartianinen E, Perola M, Boerwinkle E, Sing C. Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. of special interest Am J Hum Genet. 63:1998;595-612 This is the extensive linkage disequilibrium study of the markers generated in [50]. It has important implications for our understanding of the extent of linkage disequilibrium within a large gene with multiple polymorphisms.
52. Darvasi A. Experimental strategies for the genetic dissection of complex traits in animal models. Nat Genet. 18:1998;19-24.